Related Experiment Video
Updated: Mar 28, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during
Shaaban A Mousa1, Mohammed Shaqura, Jens Winkler
1Department of Anaesthesiology and Intensive Care Medicine, Charité University Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany Department of Anatomy, Ludwig Maximilian University Munich, Munich, Germany Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Jena, Germany Department of Internal Medicine, Paulinenkrankenhaus, Berlin, Germany.
Abstract:
Painful diabetic neuropathy is associated with impaired opioid analgesia; however, the precise mechanism in sensory neurons remains unclear. This study aimed to identify putative mechanisms involved in modified opioid responsiveness during early streptozotocin-induced diabetes in rats. In this study, we demonstrate that in diabetic animals, impaired peripheral opioid analgesia is associated with a reduction in functional mu-opioid receptor (MOR) G protein coupling. Mu-opioid receptor immunoreactive neurons colocalized with activated forms of protein kinase C (PKC) and with the receptor for advanced glycation end products (RAGE) during streptozotocin-induced diabetes. Moreover, MOR phosphorylation at Thr370 in sensory neurons of diabetic rats, and thus desensitization, was due to RAGE-dependent PKC activation. Importantly, blocking PKC activation using PKC selective inhibitor, silencing RAGE with intrathecal RAGE siRNA, or inhibiting advanced glycation end product (AGE) formation prevented sensory neuron MOR phosphorylation and, consequently, restored MOR G protein coupling and analgesic efficacy. Thus, our findings give the first in vivo evidence of a RAGE-dependent PKC-mediated heterologous MOR phosphorylation and desensitization in sensory neurons under pathological conditions such as diabetic neuropathy. This may unravel putative mechanisms and suggest possible prevention strategies of impaired opioid responsiveness.
Insights
Diabetic neuropathy impairs opioid pain relief by reducing mu-opioid receptor (MOR) function. This study reveals a RAGE-dependent PKC pathway causes MOR desensitization in sensory neurons, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Pharmacology
- Endocrinology
Background:
- Painful diabetic neuropathy is linked to reduced opioid effectiveness.
- The exact mechanisms behind this impaired analgesia in sensory neurons are not fully understood.
Purpose of the Study:
- To investigate the mechanisms of altered opioid responsiveness in early streptozotocin-induced diabetes in rats.
- To identify key molecular players in sensory neurons contributing to impaired opioid analgesia.
Main Methods:
- Utilized streptozotocin-induced diabetes model in rats.
- Examined mu-opioid receptor (MOR) G protein coupling and phosphorylation.
- Investigated the roles of Protein Kinase C (PKC), Receptor for Advanced Glycation End Products (RAGE), and advanced glycation end products (AGEs).
- Employed PKC inhibitors, RAGE siRNA, and AGE formation inhibitors.
Main Results:
- Diabetic rats showed reduced functional MOR G protein coupling and impaired peripheral opioid analgesia.
- MORs in sensory neurons colocalized with activated PKC and RAGE.
- MOR phosphorylation at Thr370, leading to desensitization, was mediated by RAGE-dependent PKC activation.
- Interventions targeting PKC, RAGE, or AGE formation restored MOR function and analgesic efficacy.
Conclusions:
- Demonstrated in vivo evidence of RAGE-dependent, PKC-mediated heterologous MOR phosphorylation and desensitization in sensory neurons during diabetic neuropathy.
- Identified a novel mechanism contributing to impaired opioid responsiveness in diabetes.
- Suggests potential therapeutic strategies for preventing or reversing opioid resistance in diabetic neuropathy.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Opioid Receptors: Overview
GPCR Desensitization
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Analgesia and Pain Management
GPCRs Regulate Adenylyl Cylase Activity